Ivermectin

Studi estratti dal podcast di Rob Mac Sweeney

• 2026REMAP-CAPICU & Critical CareIn 150 hospitalized patients with COVID-19, ivermectin did not improve organ support-free days or hospital survival compared with usual care.
• 2021REMAP-CAPICU & Critical CareIn 694 critically ill adults with COVID-19, lopinavir-ritonavir or hydroxychloroquine reduced organ support-free days compared with no antiviral therapy.
• 2020Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 PandemicInfection & AntimicrobialsIn 600 Egyptian COVID-19 patients and exposed contacts, ivermectin reduced mortality and new infections compared with hydroxychloroquine or standard care alone.
• 2021Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 InfectionInfection & AntimicrobialsIn 3349 patients with COVID-19 across 23 randomized trials, ivermectin did not improve survival compared with standard care or placebo.